• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在日本男性中,对经单核心阳性前列腺活检诊断且Gleason评分低于4分的8例患者进行根治性前列腺切除术标本的病理检查结果。

Pathological findings of radical prostatectomy specimens in Japanese men diagnosed on single core positive prostate biopsy in eight with a Gleason score less than 4.

作者信息

Miyake Hideaki, Ono Yoshiharu, Park Soo-Jeon, Hara Isao, Eto Hiroshi

机构信息

Department of Urology, Hyogo Medical Center for Adults, Akashi, Japan.

出版信息

Int J Urol. 2003 Jul;10(7):383-6. doi: 10.1046/j.1442-2042.2003.00644.x.

DOI:10.1046/j.1442-2042.2003.00644.x
PMID:12823693
Abstract

BACKGROUND

The objective of the present study was to analyze the pathological findings of radical prostatectomy specimens diagnosed on single core positive prostate biopsy in eight systematic transrectal ultrasonography (TRUS)-guided biopsies with a Gleason score </= 4.

METHODS

Between January 1993 and March 2001, 975 patients underwent TRUS-guided prostate biopsy, and 32 patients were diagnosed as having prostate cancer based only on one positive core with a Gleason score </= 4. In this study, 14 of the 32 patients who underwent radical prostatectomy without any neoadjuvant therapies were enrolled, and the pathological findings of their radical prostatectomy specimens were evaluated.

RESULTS

The clinical stage of the 14 patients was T1c in 10 and T2 in four. Cancer was detected in the prostate apex in seven patients, the middle in two, the base of the peripheral zone (PZ) in three, the lateral horn of the PZ in one and the transitional zone (TZ) one. Pathological stage of the 14 patients was pT2a in four, pT2b in six, pT3a in three and pT3b one. Gleason score of the radical prostatectomy specimens in 11 patients was also </= 4. Of the 10 patients diagnosed with cT1c, extraprostatic disease was found in only one radical prostatectomy specimen. All three patients whose cancer was detected from the base of the PZ showed pT3 disease. During the median follow-up period of 47.5 months, all patients were alive with no evidence of disease.

CONCLUSION

The prognosis of patients who were diagnosed with one core positive prostate biopsy with a Gleason score </= 4 is generally favorable; however, advanced disease tended to be observed in patients who were diagnosed with cT2a and/or whose cancer was detected from the base of PZ.

摘要

背景

本研究的目的是分析在8次系统经直肠超声(TRUS)引导下活检中,Gleason评分≤4的单核心阳性前列腺活检诊断的根治性前列腺切除术标本的病理结果。

方法

1993年1月至2001年3月期间,975例患者接受了TRUS引导下的前列腺活检,32例患者仅基于一个Gleason评分≤4的阳性核心被诊断为前列腺癌。在本研究中,32例接受了根治性前列腺切除术且未进行任何新辅助治疗的患者中有14例被纳入,其根治性前列腺切除术标本的病理结果得到评估。

结果

14例患者的临床分期为10例T1c和4例T2。7例患者在前列腺尖部发现癌症,2例在中部,3例在外周带(PZ)底部,1例在PZ侧角,1例在移行带(TZ)。14例患者的病理分期为4例pT2a,6例pT2b,3例pT3a和1例pT3b。11例根治性前列腺切除术标本的Gleason评分也≤4。在10例诊断为cT1c的患者中,仅1例根治性前列腺切除术标本发现前列腺外疾病。从PZ底部检测到癌症的所有3例患者均显示pT3疾病。在中位随访期47.5个月期间,所有患者均存活且无疾病证据。

结论

Gleason评分≤4的单核心阳性前列腺活检诊断的患者预后通常良好;然而,在诊断为cT2a和/或其癌症从PZ底部检测到的患者中倾向于观察到晚期疾病。

相似文献

1
Pathological findings of radical prostatectomy specimens in Japanese men diagnosed on single core positive prostate biopsy in eight with a Gleason score less than 4.在日本男性中,对经单核心阳性前列腺活检诊断且Gleason评分低于4分的8例患者进行根治性前列腺切除术标本的病理检查结果。
Int J Urol. 2003 Jul;10(7):383-6. doi: 10.1046/j.1442-2042.2003.00644.x.
2
[COMPARISON LOCALIZATION RESULTS BASED ON PROSTATE BIOPSY SPECIMENS WITH RESULTS BASED ON RADICAL PROSTATECTOMY SPECIMENS IN PROSTATE CANCER].[基于前列腺活检标本的前列腺癌定位结果与基于前列腺根治术标本的结果比较]
Nihon Hinyokika Gakkai Zasshi. 2016;107(2):87-92. doi: 10.5980/jpnjurol.107.87.
3
Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.对于接受广泛经直肠超声引导活检方案诊断的低危前列腺癌患者,单侧阳性活检并不能预测根治性前列腺切除术后的单侧前列腺癌。
BJU Int. 2012 Jul;110(2 Pt 2):E64-8. doi: 10.1111/j.1464-410X.2011.10762.x. Epub 2011 Nov 17.
4
Transition zone biopsy and prediction of extraprostatic extension at radical prostatectomy.前列腺移行区活检与根治性前列腺切除术中前列腺外侵犯的预测
Int J Urol. 2003 Jun;10(6):302-6; discussion 307-8. doi: 10.1046/j.1442-2042.2003.00622.x.
5
Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.临床分期为T1c与T2的前列腺腺癌根治性前列腺切除术的病理参数:病理分期降低及移行区肿瘤检出率增加。
J Urol. 2002 Aug;168(2):519-24.
6
Significance of routine transition zone biopsies in Japanese men undergoing transrectal ultrasound-guided prostate biopsies.经直肠超声引导下前列腺穿刺活检的日本男性患者常规移行区活检的意义
Int J Urol. 2005 Nov;12(11):964-8. doi: 10.1111/j.1442-2042.2005.01188.x.
7
[Clinicopathological study of prostate cancer patients who had a serum PSA level of more than 20 ng/ml and were treated by a radical prostatectomy].血清前列腺特异性抗原水平大于20 ng/ml且接受根治性前列腺切除术的前列腺癌患者的临床病理研究
Nihon Hinyokika Gakkai Zasshi. 2007 Jul;98(5):685-90. doi: 10.5980/jpnjurol1989.98.685.
8
Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.在经直肠超声(TRUS)引导下穿刺活检 Gleason 评分 3 + 4 = 7 的前列腺癌患者中,筛状形态可预测根治性前列腺切除术后分期升级。
Virchows Arch. 2015 Oct;467(4):437-42. doi: 10.1007/s00428-015-1809-5. Epub 2015 Jul 31.
9
Role of systematic ultrasound-guided staging biopsies in predicting extraprostatic extension and seminal vesicle invasion in men with prostate cancer.系统性超声引导下分期活检在预测前列腺癌男性患者前列腺外扩展和精囊侵犯中的作用。
J Clin Ultrasound. 2002 Mar-Apr;30(3):123-31. doi: 10.1002/jcu.10052.
10
Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.222例前列腺癌根治术标本的系统活检与组织学特征之间的关系:对不可触及前列腺癌患者肿瘤意义的预测不足
J Urol. 2001 Jul;166(1):104-9; discussion 109-10.